KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 86 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,230,000 | -0.3% | 556,383 | +3.2% | 0.00% | 0.0% |
Q3 2016 | $5,245,000 | +47.2% | 539,090 | +1.6% | 0.00% | 0.0% |
Q2 2016 | $3,562,000 | -22.4% | 530,816 | +3.2% | 0.00% | 0.0% |
Q1 2016 | $4,589,000 | -33.4% | 514,428 | -1.0% | 0.00% | 0.0% |
Q4 2015 | $6,888,000 | +28.3% | 519,864 | +2.0% | 0.00% | 0.0% |
Q3 2015 | $5,369,000 | -57.4% | 509,882 | +10.0% | 0.00% | -50.0% |
Q2 2015 | $12,615,000 | -3.1% | 463,627 | +9.1% | 0.00% | 0.0% |
Q1 2015 | $13,012,000 | +58.7% | 425,106 | +94.0% | 0.00% | +100.0% |
Q4 2014 | $8,200,000 | +66.4% | 219,078 | +55.4% | 0.00% | 0.0% |
Q3 2014 | $4,927,000 | -20.7% | 141,013 | +5.7% | 0.00% | 0.0% |
Q2 2014 | $6,213,000 | +148.4% | 133,469 | +64.9% | 0.00% | – |
Q1 2014 | $2,501,000 | -11.8% | 80,963 | -34.5% | 0.00% | -100.0% |
Q4 2013 | $2,834,000 | – | 123,666 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |